Clinical evaluation of benzydamine for treatment of vaginitis: results of a randomized study with emphasis on functional symptoms.
The antiinflammatory effect of benzydamine compared with a placebo in a randomized study is reported in the treatment of trichomonas- and candida-induced vaginitis. The reduction of inflammation and its clinical manifestations was determined and statistically analysed, demonstrating that benzydamine has a definite effect on the early reduction of functional pain and symptoms.
D000282:Administration, Intravaginal; D000287:Administration, Topical; D000893:Anti-Inflammatory Agents; D001591:Benzydamine / Q000008:administration & dosage*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D011720:Pyrazoles / Q000008:administration & dosage*; D011897:Random Allocation; D007507:Therapeutic Irrigation; D014247:Trichomonas Vaginitis / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D011720:Pyrazoles; D001591:Benzydamine